Trial Outcomes & Findings for Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy (NCT NCT01525420)

Results Overview

30-Day point prevalence abstinence at 6 months post treatment

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

121 participants

Primary outcome timeframe

6 months

Results posted on

2014-05-26

Participant Flow

Participant milestones

Participant milestones
Measure	Acceptance & Commitment Therapy (ACT) ACT Acceptance \& Commitment Therapy (ACT): ACT This is the experimental arm of the study. This included 5 weekly sessions of ACT therapy via telephone.	Cognitive Behavioral Therapy (CBT) CBT Cognitive Behavioral Therapy (CBT): CBT This is the control arm of the study. This included 5 weekly sessions of CBT therapy via telephone.
Overall Study STARTED	59	62
Overall Study COMPLETED	43	38
Overall Study NOT COMPLETED	16	24

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Acceptance & Commitment Therapy (ACT) n=59 Participants ACT Acceptance \& Commitment Therapy (ACT): This is the experimental arm of the study. This included 5 weekly sessions of ACT therapy via telephone.	Cognitive Behavioral Therapy (CBT) n=62 Participants CBT Cognitive Behavioral Therapy (CBT): ACT: This is the control arm of the study. This included 5 weekly sessions of CBT therapy via telephone.	Total n=121 Participants Total of all reporting groups
Age, Continuous	39.6 years STANDARD_DEVIATION 9.5 • n=5 Participants	38.6 years STANDARD_DEVIATION 10.2 • n=7 Participants	39.1 years STANDARD_DEVIATION 9.8 • n=5 Participants
Sex: Female, Male Female	39 Participants n=5 Participants	45 Participants n=7 Participants	84 Participants n=5 Participants
Sex: Female, Male Male	20 Participants n=5 Participants	17 Participants n=7 Participants	37 Participants n=5 Participants

PRIMARY outcome

Timeframe: 6 months

30-Day point prevalence abstinence at 6 months post treatment

Outcome measures

Outcome measures
Measure	Acceptance & Commitment Therapy (ACT) n=59 Participants ACT Acceptance \& Commitment Therapy (ACT): ACT	Cognitive Behavioral Therapy (CBT) n=62 Participants CBT Cognitive Behavioral Therapy (CBT): CBT
Number of Participants Who Stopped Smoking by 6 Month Post Treatment	18 participants	14 participants

SECONDARY outcome

Timeframe: 6-month

7-day and 24-hour point prevalence quit rates

Outcome measures

Outcome data not reported

Adverse Events

Acceptance & Commitment Therapy (ACT)

Serious events: 2 serious events

Other events: 0 other events

Deaths: 0 deaths

Cognitive Behavioral Therapy (CBT)

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure	Acceptance & Commitment Therapy (ACT) n=59 participants at risk ACT Acceptance \& Commitment Therapy (ACT): ACT	Cognitive Behavioral Therapy (CBT) n=62 participants at risk CBT Cognitive Behavioral Therapy (CBT): CBT
Social circumstances No AE term known- see description	1.7% 1/59	0.00% 0/62
Social circumstances No AE term known - see description	1.7% 1/59	0.00% 0/62

Other adverse events

Adverse event data not reported

Additional Information

Jonathan B. Bricker, Ph.D.

Fred Hutchinson Cancer Research Center

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place